These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34719478)

  • 1. Circulating CXCL13 could be serving as a biomarker for chronic lymphocytic leukemia severity.
    Aref S; Atia D; Ramez A; Zeid TA; Gouda E
    Cancer Biomark; 2022; 34(1):105-111. PubMed ID: 34719478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXC chemokine ligand 13 and galectin-9 plasma levels collaboratively provide prediction of disease activity and progression-free survival in chronic lymphocytic leukemia.
    Ahmed HA; Nafady A; Ahmed EH; Hassan EEN; Soliman WGM; Elbadry MI; Allam AA
    Ann Hematol; 2024 Mar; 103(3):781-792. PubMed ID: 37946029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of Serum CD200 Concentrations in Chronic Lymphocytic Leukemia.
    Aref S; El Tantawy A; Gouda E; Ayed M
    Asian Pac J Cancer Prev; 2023 Jun; 24(6):1943-1948. PubMed ID: 37378922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 plasma levels function as a biomarker for disease activity in patients with chronic lymphocytic leukemia.
    Sivina M; Xiao L; Kim E; Vaca A; Chen SS; Keating MJ; Ferrajoli A; Estrov Z; Jain N; Wierda WG; Huang X; Chiorazzi N; Burger JA
    Leukemia; 2021 Jun; 35(6):1610-1620. PubMed ID: 33087831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Plasma miR-29a Evaluation in Chronic Lymphocytic Leukemia Patients.
    Aref S; El Tantawy A; Aref M; El Agdar M; Ayed M
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2439-2444. PubMed ID: 37505778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
    Nowakowski GS; Hoyer JD; Shanafelt TD; Zent CS; Call TG; Bone ND; Laplant B; Dewald GW; Tschumper RC; Jelinek DF; Witzig TE; Kay NE
    J Clin Oncol; 2009 Apr; 27(11):1844-9. PubMed ID: 19255329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
    Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
    Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia.
    Matuszak M; Lewandowski K; Czyż A; Kiernicka-Parulska J; Przybyłowicz-Chalecka A; Jarmuż-Szymczak M; Lewandowska M; Komarnicki M
    Leuk Res; 2016 Aug; 47():166-71. PubMed ID: 27376546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia.
    Bürkle A; Niedermeier M; Schmitt-Gräff A; Wierda WG; Keating MJ; Burger JA
    Blood; 2007 Nov; 110(9):3316-25. PubMed ID: 17652619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.
    Johansson P; Eisele L; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J; Nückel H
    Leuk Res; 2010 Jul; 34(7):892-8. PubMed ID: 20353875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients.
    Khalifa MM; Zaki NE; Nazier AA; Moussa MA; Haleem RA; Rabie MA; Mansour AR
    J Egypt Natl Canc Inst; 2021 Dec; 33(1):37. PubMed ID: 34866170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia and prognostic factors.
    Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
    Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia.
    De Luca L; D'Arena G; Simeon V; Trino S; Laurenzana I; Caivano A; La Rocca F; Villani O; Mansueto G; Deaglio S; Innocenti I; Laurenti L; Molica S; Pietrantuono G; De Stradis A; Del Vecchio L; Musto P
    Leuk Lymphoma; 2017 Jun; 58(6):1424-1432. PubMed ID: 27739922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
    Lai R; O'Brien S; Maushouri T; Rogers A; Kantarjian H; Keating M; Albitar M
    Cancer; 2002 Sep; 95(5):1071-5. PubMed ID: 12209693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
    Weinberg JB; Volkheimer AD; Chen Y; Beasley BE; Jiang N; Lanasa MC; Friedman D; Vaccaro G; Rehder CW; Decastro CM; Rizzieri DA; Diehl LF; Gockerman JP; Moore JO; Goodman BK; Levesque MC
    Am J Hematol; 2007 Dec; 82(12):1063-70. PubMed ID: 17654680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.
    Gogia A; Raina V; Gupta R; Gajendra S; Kumar L; Sharma A; Kumar R; Vishnubhatla S
    Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):514-7. PubMed ID: 24656596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Significance of Combined Expression of ZAP-70 and CD38 in Chronic Lymphocytic Leukemia.
    Assem M; Abdel Hamid T; Kohla S; Arsanyos S
    J Egypt Natl Canc Inst; 2009 Dec; 21(4):287-97. PubMed ID: 21415865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
    Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum copper is a simple but valuable prognostic marker in B-cell chronic lymphocytic leukemia.
    Labib HA; Hassanein M; Etewa RL
    Int J Hematol; 2014 Dec; 100(6):575-81. PubMed ID: 25293553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
    Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
    Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.